Femasys to Enact 1-for-20 Reverse Stock Split Effective June 5th
Summary
Femasys Inc. will implement a 1-for-20 reverse stock split, effective June 5, 2026, with shares trading split-adjusted from June 8. This action follows shareholder approval sought in earlier proxy filings (PRE 14A, DEF 14A) to address Nasdaq's minimum bid price requirement and avoid delisting. While preventing immediate delisting, the split does not resolve the company's underlying financial challenges, including the 'going concern' warning noted in its 10-K filing. This move will significantly reduce outstanding shares and increase the per-share price.
At the time of this announcement, FEMY was trading at $0.34 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $22.2M. The 52-week trading range was $0.31 to $1.11. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.